These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21183785)

  • 1. Cytokinesis failure and attenuation: new findings in Fanconi anemia.
    Mason PJ; Bessler M
    J Clin Invest; 2011 Jan; 121(1):27-30. PubMed ID: 21183785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients.
    Ceccaldi R; Briot D; Larghero J; Vasquez N; Dubois d'Enghien C; Chamousset D; Noguera ME; Waisfisz Q; Hermine O; Pondarre C; Leblanc T; Gluckman E; Joenje H; Stoppa-Lyonnet D; Socié G; Soulier J
    J Clin Invest; 2011 Jan; 121(1):184-94. PubMed ID: 21183791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells.
    Vinciguerra P; Godinho SA; Parmar K; Pellman D; D'Andrea AD
    J Clin Invest; 2010 Nov; 120(11):3834-42. PubMed ID: 20921626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in Fanconi anemia hematopoiesis and disease progression.
    Du W; Adam Z; Rani R; Zhang X; Pang Q
    Antioxid Redox Signal; 2008 Nov; 10(11):1909-21. PubMed ID: 18627348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.
    Carreau M; Gan OI; Liu L; Doedens M; McKerlie C; Dick JE; Buchwald M
    Blood; 1998 Apr; 91(8):2737-44. PubMed ID: 9531583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fanconi Anemia Pathway and Fertility.
    Tsui V; Crismani W
    Trends Genet; 2019 Mar; 35(3):199-214. PubMed ID: 30683429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial respiratory complex I defects in Fanconi anemia.
    Cappelli E; Ravera S; Vaccaro D; Cuccarolo P; Bartolucci M; Panfoli I; Dufour C; Degan P
    Trends Mol Med; 2013 Sep; 19(9):513-4. PubMed ID: 23932594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress and DNA repair biology of the Fanconi anemia pathway.
    Longerich S; Li J; Xiong Y; Sung P; Kupfer GM
    Blood; 2014 Oct; 124(18):2812-9. PubMed ID: 25237197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry.
    Auerbach AD; Allen RG
    Cancer Genet Cytogenet; 1991 Jan; 51(1):1-12. PubMed ID: 1984836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.
    Rosenberg PS; Alter BP; Ebell W
    Haematologica; 2008 Apr; 93(4):511-7. PubMed ID: 18322251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.
    Kruyt FA; Dijkmans LM; van den Berg TK; Joenje H
    Blood; 1996 Feb; 87(3):938-48. PubMed ID: 8562965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fanconi anemia.
    Soulier J
    Hematology Am Soc Hematol Educ Program; 2011; 2011():492-7. PubMed ID: 22160080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of malignancy and clonal chromosomal abnormalities in Fanconi anemia.
    Vundinti BR; Korgaonkar S; Ghosh K
    Indian J Cancer; 2010; 47(4):397-9. PubMed ID: 21131752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fanconi Anemia Signaling and Cancer.
    Nepal M; Che R; Zhang J; Ma C; Fei P
    Trends Cancer; 2017 Dec; 3(12):840-856. PubMed ID: 29198440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A defined role for multiple Fanconi anemia gene products in DNA-damage-associated ubiquitination.
    Tan W; Deans AJ
    Exp Hematol; 2017 Jun; 50():27-32. PubMed ID: 28315701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of Fanconi anemia.
    Kupfer GM; Näf D; D'Andrea AD
    Hematol Oncol Clin North Am; 1997 Dec; 11(6):1045-60. PubMed ID: 9443045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two different karyotypes with 1q abnormalities in a patient with Fanconi anemia.
    Oliveira NI; Ribeiro EM; Raimondi SC; Bittencourt MA; Pasquini R; Cavalli IJ
    Leuk Res; 2002 Nov; 26(11):1047-9. PubMed ID: 12363475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fanconi anemia and the development of leukemia.
    Alter BP
    Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Wu T; Gluckman E; Soulier J; Surralles J; Castella M; van der Wal JE; Wennerberg J; Califano J; Velleuer E; Dietrich R; Ebell W; Bloemena E; Joenje H; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2008 Nov; 100(22):1649-53. PubMed ID: 19001603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia with complex hypodiploidy and loss of heterozygosity of 17p in a boy with Fanconi anemia.
    Woo HI; Kim HJ; Lee SH; Yoo KH; Koo HH; Kim SH
    Ann Clin Lab Sci; 2011; 41(1):66-70. PubMed ID: 21325258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.